Navigation Links
Hospira Works With FDA to Help Avert Methotrexate Shortage; Shipping One Month's Supply of New Product Immediately and on Track to Ensure Sustainable Supply
Date:2/21/2012

LAKE FOREST, Ill., Feb. 21, 2012 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, announced today that it began shipping 31,000 vials of 1-gram methotrexate to U.S. hospitals and treatment centers on Monday, enough for one month's U.S. demand. In addition, Hospira continues to work closely with the U.S. Food and Drug Administration (FDA) to ensure that by mid-March the company will have produced enough supply of this life-saving drug for the full year.

(Photo: http://photos.prnewswire.com/prnh/20120221/CG56759)

Methotrexate is an injectable drug used to treat a variety of cancerous and rheumatologic conditions, including acute lymphoblastic leukemia (ALL), a childhood blood cancer.

Hospira began working to address the U.S. methotrexate shortage late last year by increasing production of the product when it first became aware of potential manufacturing challenges with other suppliers. Since then, Hospira has worked with the FDA to secure new supplies of the drug's active ingredient, and by mid-March will have manufactured enough 1-gram methotrexate to meet expected full market demand and also to begin establishing a safety stock to ensure patients and their families do not have to face fear of a shortage again. 

During an FDA briefing regarding progress on drug shortages today at the FDA's headquarters in White Oak, Md., Hospira CEO F. Michael Ball said:

"Commissioner Hamburg, ladies and gentlemen, it is an honor for me to be here today to represent Hospira and to show our continued support to our patients and U.S. hospitals. Hospira, headquartered in Illinois, is the largest provider of generic injectable products in the world, and I am proud to announce that thro
'/>"/>

SOURCE Hospira, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Hospira Announces Start of U.S. Phase III Biosimilar EPO Clinical Program
2. Hospira to Host Conference Call for Fourth-Quarter 2011 Results and 2012 Projections
3. Hospira to Present at the J.P. Morgan 30th Annual Healthcare Conference Jan. 10, 2012
4. Hospira Reports Third-Quarter 2011 Results
5. Hospira Announces Certain Preliminary Third-Quarter 2011 Results
6. Hospira to Host Conference Call for Third-Quarter 2011 Results
7. Hospira Announces Positive Results From Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients
8. Hospira to Host 2011 Investor Day
9. Hospira to Present at the Morgan Stanley Global Healthcare Conference
10. Hospira Expands Board of Directors
11. Hospira Announces U.S. Approval of Solution Version of Gemcitabine Injection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... MENLO PARK, Calif. , Aug. 29, 2014 ... DMPI) ("DelMar" "the Company") today announced the filing of ... recently changed its fiscal year end to June 30th ... common stock on a national securities exchange in the ... filed with the United States Securities Exchange Commission can ...
(Date:8/29/2014)... DUBLIN , Aug. 29, 2014 ... "Global Orthopedic Soft Tissue Repair Devices Market 2014-2018" ... soft tissues are the mass of cells that connect, ... orthopedic soft tissues such as tendons, ligaments, cartilage, fascia, ... the degeneration of these tissues with age result in ...
(Date:8/29/2014)... , Aug. 29, 2014 ... PHG AEX: PHIA) ... European Society of Cardiology (ESC) Congress ... highlighting the full range of its cardiology solutions serving clinicians ... from prevention and diagnosis, to ...
Breaking Medicine Technology:DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 2DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 3DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 4DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 5Global Orthopedic Soft Tissue Repair Devices Market 2014-2018: Key Vendors are ArthroCare, Biomet, DePuy Synthes and Smith & Nephew 2Global Orthopedic Soft Tissue Repair Devices Market 2014-2018: Key Vendors are ArthroCare, Biomet, DePuy Synthes and Smith & Nephew 3Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 2Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 3Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 4Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 5
... 26 Brainlab announced the availability of ExacTrac® Infrared Monitoring, ... during radiation therapy treatments, at the American Association of Physicists in ... , , ... tool used by many cancer care centers for patient setup; however, ...
... ,, ROCKVILLE, Md. , July 26 Sequella, Inc., ... announced today the publication of studies in the scientific journal Antimicrobial ... for the treatment of TB, and TMC207, Tibotec lead TB drug candidate: ... Reddy, V.M., L. ...
Cached Medicine Technology:Brainlab Offers Real-Time Monitoring for IGRT 2Two New Tuberculosis (TB) Drugs Show Significant Synergy In Vitro 2Two New Tuberculosis (TB) Drugs Show Significant Synergy In Vitro 3
(Date:8/30/2014)... Recently, Skmen.com, a well-known clothing manufacturer, has ... . Before the middle of September, all the company’s ... from 15 to 30 percent off. , As ... outfits are carefully made and come with quality guarantees. ... wearers. Skmen.com is popular for its fashionable, high quality ...
(Date:8/30/2014)... 2014 Patients suffering from vitiligo can ... a new review published by Daily Gossip. , ... so there is no wonder that numerous sufferers search ... Vitiligo Treatment is one of the most appreciated such ... promises to stop the spread of this disorder immediately, ...
(Date:8/30/2014)... Albany, New York (PRWEB) August 30, 2014 ... a combination of Nutrition and Pharameuticals. Nutraceuticals is ... by extracting healthy ingredients from natural food sources. ... specific health benefits to the human body. Nutraceutical ... multivitamins, diet supplements, fortified foods and more. Although ...
(Date:8/30/2014)... 30, 2014 Acne is a common problem millions ... is nothing more than a daily nuisance, for some, it can ... of acne can even lead to dramatic mood swings and depression. ... anything to clear up their skin. In some cases, that can ... through trial and error, those on a quest for clearer skin ...
(Date:8/30/2014)... August 30, 2014 Continuing to meet ... is expanding with the addition of a new doctor ... who has provided leading-edge skin care in Grand Rapids ... , “As a doctor, my passion is making ... partnering with Forefront Dermatology, I’m better able to focus ...
Breaking Medicine News(10 mins):Health News:Huge Deals On 2014 Long Casual Dresses Unveiled By Skmen.com 2Health News:Natural Vitiligo Treatment Review Exposes Fast Method for Skin Repigmentation 2Health News:A Granular Analysis of the Nutraceutical Ingredients Market by Transparency Market Research 2Health News:A Granular Analysis of the Nutraceutical Ingredients Market by Transparency Market Research 3Health News:A Granular Analysis of the Nutraceutical Ingredients Market by Transparency Market Research 4Health News:Acne Treatment Reviews Added to Popular Treatment Website 2Health News:Expanding Care at the Forefront of Dermatology 2
... you regularly take aspirin or antiplatelet medications? Do you ... before dental procedures or surgeries? According to a study ... , the clinical, peer-reviewed journal of the Academy of ... surgical procedure places a patient at greater risk of ...
... The HHS Office of HIV/AIDS Policy,s AIDS.gov will recognize ... a special focus on reducing HIV/AIDS-related stigma and promoting HIV ... AIDS Day will also mark the second anniversary of AIDS.gov, ... resources. , , AIDS.gov is ...
... 25 Sandy Spindler had five good reasons,to quit ... mother of five,was awarded the $5,000 grand prize in ... ClearWay Minnesota(SM) and QUITPLAN,Services. More than 2,500 Minnesotans, including ... chance to win. , ...
... The overall incidence of cancer and death due to cancer ... the United States, according to a report published in the ... National Cancer Institute . , Each year the American Cancer ... Cancer Institute, and the North American Association of Central Cancer ...
... Spanish . , A new report from the ... since the report was first issued in 1998, both incidence ... both men and women, driven largely by declines in some ... notes that, although the decreases in overall cancer incidence and ...
... University of Pennsylvania School of Medicine have found ... in kidney transplants and complications during the first ... Kamoun MD, PhD, Professor of Pathology and Laboratory ... Histocompatibility Laboratory, and Harold Feldman MD, MSCE, Professor ...
Cached Medicine News:Health News:Disclosure of medication can save a patient's life 2Health News:HHS' AIDS.gov to Use Blogs, Virtual Worlds, and Social Networks to Deliver HIV Information for World AIDS Day 2008 2Health News:Mother of Five Wins $5,000 in Minnesota Quit-Smoking Contest 2Health News:Mother of Five Wins $5,000 in Minnesota Quit-Smoking Contest 3Health News:Annual report to the nation finds declines in cancer incidence and death rates 2Health News:Annual report to the nation finds declines in cancer incidence and death rates 3Health News:Annual report to the nation finds declines in cancer incidence and death rates 4Health News:Annual report to the nation finds declines in cancer incidence and death rates 5Health News:Understanding donor-recipient genetics could decrease early kidney transplant complications 2
... BD Beaver Clear Cornea Incision System ... specifically for the Cataract surgeon. The System ... an alternative to costly diamond knives. ... shield that is designed to both protects ...
... Built on the market leading optical ... 500 has been optimized for even better ... illumination system, including a new XHL Xenon ... the cornea and clear, high resolution images ...
The NIAGARA Thermal Retention System (TRS) maintains the temperature of prewarmed irrigation fluid continuously as it is delivered through the Corson®, Surgiflex® WAVE™, or Surgiflex D...
... the EZ Meter and press the measurement ... measurement results on its large color LCD ... printout makes this the ideal instrument for ... addition to being extremely easy-to-use, the EZ-200 ...
Medicine Products: